These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 18097567

  • 1. Live cell vaccines expressing B7.1, monocyte chemoattractant protein 1 and granulocyte-macrophage colony stimulation factor derived from mouse HPV16-transformed cells.
    Lakatosová-Andelová M, Jinoch P, Dusková M, Marinov I, Vonka V.
    Int J Oncol; 2008 Jan; 32(1):265-71. PubMed ID: 18097567
    [Abstract] [Full Text] [Related]

  • 2. Combined suicide gene and immunostimulatory gene therapy using AAV-mediated gene transfer to HPV-16 transformed mouse cell: decrease of oncogenicity and induction of protection.
    Janousková O, Síma P, Kunke D.
    Int J Oncol; 2003 Mar; 22(3):569-77. PubMed ID: 12579310
    [Abstract] [Full Text] [Related]

  • 3. Immunization with live HPV-16-transformed mouse cells expressing the herpes simplex thymidine kinase and either GM-CSF or IL-2.
    Jinoch P, Zak R, Janousková O, Kunke D, Rittich S, Duskova M, Sobotkova E, Marinov I, Andelova M, Smahel M, Vonka V.
    Int J Oncol; 2003 Sep; 23(3):775-83. PubMed ID: 12888917
    [Abstract] [Full Text] [Related]

  • 4. Treatment of minimal residual disease after surgery or chemotherapy in mice carrying HPV16-associated tumours: Cytokine and gene therapy with IL-2 and GM-CSF.
    Mikysková R, Indrová M, Símová J, Jandlová T, Bieblová J, Jinoch P, Bubeník J, Vonka V.
    Int J Oncol; 2004 Jan; 24(1):161-7. PubMed ID: 14654953
    [Abstract] [Full Text] [Related]

  • 5. Chemotherapy and immunotherapy of tumours induced by gene-modified HPV16-transformed cells.
    Sobotková E, Dusková M, Smahel M, Holán V, Janousková O, Vonka V.
    Oncol Rep; 2004 Oct; 12(4):877-83. PubMed ID: 15375516
    [Abstract] [Full Text] [Related]

  • 6. Chemoimmunotherapy in mice carrying HPV16-associated, MHC class I+ and class I- tumours: Effects of CBM-4A potentiated with IL-2, IL-12, GM-CSF and genetically modified tumour vaccines.
    Indrová M, Bubeník J, Mikysková R, Mendoza L, Símová J, Bieblová J, Jandlová T, Jinoch P, Smahel M, Vonka V, Pajtasz-Piasecka E.
    Int J Oncol; 2003 Mar; 22(3):691-5. PubMed ID: 12579325
    [Abstract] [Full Text] [Related]

  • 7. Characteristics of ovarian cancer cells transduced by the bicistronic retroviral vector containing GM-CSF and HSV-TK genes.
    Guan J, Ma L, Wei L.
    Chin Med J (Engl); 2001 Feb; 114(2):147-51. PubMed ID: 11780195
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Preclinical evaluation of "whole" cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genes.
    Ali SA, McLean CS, Boursnell ME, Martin G, Holmes CL, Reeder S, Entwisle C, Blakeley DM, Shields JG, Todryk S, Vile R, Robins RA, Rees RC.
    Cancer Res; 2000 Mar 15; 60(6):1663-70. PubMed ID: 10749137
    [Abstract] [Full Text] [Related]

  • 11. Monocyte chemoattractant protein-1 gene delivery enhances antitumor effects of herpes simplex virus thymidine kinase/ganciclovir system in a model of colon cancer.
    Kagaya T, Nakamoto Y, Sakai Y, Tsuchiyama T, Yagita H, Mukaida N, Kaneko S.
    Cancer Gene Ther; 2006 Apr 15; 13(4):357-66. PubMed ID: 16224495
    [Abstract] [Full Text] [Related]

  • 12. A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes.
    Hu ZB, Wu CT, Wang H, Zhang QW, Wang L, Wang RL, Lu ZZ, Wang LS.
    Cancer Gene Ther; 2008 Mar 15; 15(3):173-82. PubMed ID: 18157145
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Vaccine effect of granulocyte-macrophage colony-stimulating factor or CD80 gene-transduced murine hematopoietic tumor cells and their cooperative enhancement of antitumor immunity.
    Nakazaki Y, Tani K, Lin ZT, Sumimoto H, Hibino H, Tanabe T, Wu MS, Izawa K, Hase H, Takahashi S, Tojo A, Azuma M, Hamada H, Mori S, Asano S.
    Gene Ther; 1998 Oct 15; 5(10):1355-62. PubMed ID: 9930341
    [Abstract] [Full Text] [Related]

  • 20. Influence of gene-modified (IL-7, IL-4, and B7) tumor cell vaccines on tumor antigen presentation.
    Cayeux S, Richter G, Noffz G, Dörken B, Blankenstein T.
    J Immunol; 1997 Mar 15; 158(6):2834-41. PubMed ID: 9058819
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.